{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-13",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-7/paragraph-13.json",
  "legislation": "uksi/2013/2033",
  "legislation_title": "The Veterinary Medicines Regulations 2013",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013",
  "path": "schedule/7/paragraph/13",
  "kind": "paragraph",
  "number": "13",
  "heading": "Fees for an application for an exceptional marketing authorisation (immunological or biological non-immunological)",
  "text": "The fee for an application for an exceptional marketing authorisation for an immunological product or a biological veterinary medicinal product that is not immunological is in accordance with the following table.\nFees for an exceptional marketing authorisation for an immunological product or a biological veterinary medicinal product that is not immunological\nApplication\nProvisional (£)\nLimited (£)\nBase fee:\n10,810\n5,887\nThe following fees are in addition to the base fee—\nAdditional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom, and for each new combination of active ingredients:\n5,650\n3,702\nAdditional fee for each adjuvant or preservative not previously included in a veterinary medicinal product authorised in the United Kingdom and for each new combination of adjuvants or preservatives:\n1,350\n672\nMore than one antigenic component – fee for each additional component:\n1,190\n675\nMore than one species – fee for each additional species:\n4,060\n2,690\nMore than one route of administration – fee for each additional route of administration:\n4,060\n2,690\nSimultaneous application - fee for each additional product in the application:\n2,895\n1,447",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Sch. 7 para. 13 inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 168(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 7 para. 13 heading substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 168(b)"
    },
    {
      "type": "E",
      "label": "E1",
      "text": "This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/2033/schedule/7/paragraph/13",
    "retrieved_at": "2026-10-29T00:44:44.019972+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}